{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:42:23Z","timestamp":1779190943601,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"publisher","award":["223273"],"award-info":[{"award-number":["223273"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The South-Eastern Norway Regional Health Authority","award":["2017-097"],"award-info":[{"award-number":["2017-097"]}]},{"name":"Department of Psychiatric Research"},{"name":"Diakonhjemmet Hospital"},{"name":"Center for Mind\/Brain Sciences"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.schres.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T18:05:17Z","timestamp":1555610717000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Antipsychotic treatment and basal ganglia volumes: Exploring the role of receptor occupancy, dosage and remission status"],"prefix":"10.1016","volume":"208","author":[{"given":"Alessia","family":"Di Sero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-4809","authenticated-orcid":false,"given":"Kjetil N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stener","family":"Nerland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-548X","authenticated-orcid":false,"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Jovicich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.04.002_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2019.04.002_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"37","key":"10.1016\/j.schres.2019.04.002_bb0015","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1523\/JNEUROSCI.1929-08.2008","article-title":"Hierarchical organization of human cortical networks in health and schizophrenia","volume":"28","author":"Bassett","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-9964(02)00526-1","article-title":"Caudate and putamen volumes in good and poor outcome patients with schizophrenia","volume":"64","author":"Buchsbaum","year":"2003","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2019.04.002_bb0025","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","article-title":"Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs","volume":"151","author":"Chakos","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.04.002_bb0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S0033291708004212","article-title":"Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment","volume":"39","author":"Chua","year":"2009","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.euroneuro.2012.09.001","article-title":"Disturbed grey matter coupling in schizophrenia","volume":"23","author":"Collin","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.schres.2019.04.002_bb0040","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/ajp.156.8.1200","article-title":"Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics","volume":"156","author":"Corson","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2019.04.002_bb0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0006-3223(02)01421-X","article-title":"The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naive and medicated states","volume":"52","author":"Corson","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.04.002_bb0050","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.pnpbp.2008.09.020","article-title":"Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine","volume":"32","author":"Crespo-Facorro","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"07","key":"10.1016\/j.schres.2019.04.002_bb0055","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1017\/S003329171000200X","article-title":"Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features","volume":"41","author":"Crespo-Facorro","year":"2011","journal-title":"Psychol. Med."},{"issue":"9","key":"10.1016\/j.schres.2019.04.002_bb0060","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2019.04.002_bb0065","first-page":"438","article-title":"Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review","volume":"20","author":"Ebdrup","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.schres.2019.04.002_bb0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.04.002_bb0075","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"issue":"20","key":"10.1016\/j.schres.2019.04.002_bb0080","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.schres.2019.04.002_bb0085","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.neubiorev.2013.06.001","article-title":"Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies","volume":"37","author":"Fusar-Poli","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.schres.2019.04.002_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0447.2010.01582.x","article-title":"The effects of lithium and anticonvulsants on brain structure in bipolar disorder","volume":"122","author":"Germana","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2019.04.002_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroimage.2018.04.054","article-title":"Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor","volume":"176","author":"Guma","year":"2018","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.schres.2019.04.002_bb0100","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1176\/ajp.155.12.1711","article-title":"Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia","volume":"155","author":"Gur","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2019.04.002_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuroscience.2014.10.008","article-title":"The place of dopamine in the cortico-basal ganglia circuit","volume":"282c","author":"Haber","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2016.18.1\/shaber","article-title":"Corticostriatal circuitry","volume":"18","author":"Haber","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2019.04.002_bb0115","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.neuroimage.2006.07.036","article-title":"Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data","volume":"33","author":"Hagler","year":"2006","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.schres.2019.04.002_bb0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/schbul\/sbs118","article-title":"Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects","volume":"39","author":"Haijma","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2019.04.002_bb0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pscychresns.2010.01.001","article-title":"Investigating relationships between cortical thickness and cognitive performance in patients with schizophrenia and healthy adults","volume":"182","author":"Hartberg","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2019.04.002_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nicl.2017.11.004","article-title":"The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: analysis of 778 subjects","volume":"17","author":"Hashimoto","year":"2018","journal-title":"NeuroImage. Clin."},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hbm.23844","article-title":"An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers","volume":"39","author":"Hawkins","year":"2018","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.schres.2019.04.002_bb0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.04.002_bb0145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jamapsychiatry.2016.0178","article-title":"Dopamine-related disruption of functional topography of striatal connections in unmedicated patients with schizophrenia","volume":"73","author":"Horga","year":"2016","journal-title":"JAMA Psychiat."},{"issue":"2","key":"10.1016\/j.schres.2019.04.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2574","article-title":"Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis","volume":"32","author":"Huhtaniska","year":"2017","journal-title":"Hum. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2019.04.002_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1503\/jpn.140163","article-title":"Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness","volume":"40","author":"Jorgensen","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2019.04.002_bb0160","first-page":"1","article-title":"Increased MRI-based cortical grey\/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder","author":"Jorgensen","year":"2016","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.schres.2019.04.002_bb0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00406-015-0650-9","article-title":"First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia","volume":"266","author":"Jorgensen","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroimage.2009.02.010","article-title":"MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths","volume":"46","author":"Jovicich","year":"2009","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.schres.2019.04.002_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"8934","key":"10.1016\/j.schres.2019.04.002_bb0180","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(94)90599-1","article-title":"Changes in caudate volume with neuroleptic treatment","volume":"344","author":"Keshavan","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2019.04.002_bb0185","series-title":"Organization of the Globus Pallidus, Handbook of Basal Ganglia Structure and Function","first-page":"259","author":"Kita","year":"2016"},{"key":"10.1016\/j.schres.2019.04.002_bb0190","first-page":"1","article-title":"Alcohol use is associated with thinner cerebral cortex and larger ventricles in schizophrenia, bipolar disorder and healthy controls","author":"Lange","year":"2016","journal-title":"Psychol. Med."},{"issue":"19","key":"10.1016\/j.schres.2019.04.002_bb0195","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.90.19.8861","article-title":"Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies","volume":"90","author":"Levey","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.schres.2019.04.002_bb0200","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1017\/S0033291711002157","article-title":"Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment","volume":"42","author":"Li","year":"2012","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2019.04.002_bb0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2019.04.002_bb0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fnins.2015.00379","article-title":"A comparison of FreeSurfer-generated data with and without manual intervention","volume":"9","author":"McCarthy","year":"2015","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2019.04.002_bb0215","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0006-3223(96)00110-2","article-title":"The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography","volume":"41","author":"Miller","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.04.002_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.schres.2015.03.001","article-title":"Brain structure abnormalities in first-episode psychosis patients with persistent apathy","volume":"164","author":"Morch-Johnsen","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/sbw130","article-title":"Auditory cortex characteristics in schizophrenia: associations with auditory hallucinations","volume":"43","author":"Morch-Johnsen","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2019.04.002_bb0230","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/JCP.0b013e3182979a0a","article-title":"Estimated dopamine D(2) receptor occupancy and remission in schizophrenia: analysis of the CATIE data","volume":"33","author":"Moriguchi","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.04.002_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2007.09.015","article-title":"Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication","volume":"98","author":"Nesvag","year":"2008","journal-title":"Schizophr. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.schres.2019.04.002_bb0240","first-page":"81","article-title":"Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man","volume":"10","author":"Nyberg","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2019.04.002_bb0245","first-page":"227","article-title":"Mapping dopamine receptors in the human brain","volume":"27","author":"Palacios","year":"1988","journal-title":"J. Neural Transm. Suppl."},{"issue":"3","key":"10.1016\/j.schres.2019.04.002_bb0250","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1017\/S0033291718001010","article-title":"Structural covariance and cortical reorganisation in schizophrenia: a MRI-based morphometric study","volume":"49","author":"Palaniyappan","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2019.04.002_bb0255","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2011.07.060","article-title":"Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement","volume":"198","author":"Redgrave","year":"2011","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.schres.2019.04.002_bb0260","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.biopsych.2011.11.026","article-title":"Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder","volume":"71","author":"Rimol","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.04.002_bb0265","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/schbul\/sbr189","article-title":"Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data","volume":"39","author":"Sakurai","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2019.04.002_bb0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.yco.0000214339.06507.d8","article-title":"Effects of antipsychotics on brain structure","volume":"19","author":"Scherk","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.04.002_bb0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/cn400189s","article-title":"Clozapine, a fast-off-D2 antipsychotic","volume":"5","author":"Seeman","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.schres.2019.04.002_bb0280","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2013"},{"issue":"6","key":"10.1016\/j.schres.2019.04.002_bb0285","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/15622975.2016.1245441","article-title":"Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders","volume":"18","author":"Steen","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2019.04.002_bb0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pnpbp.2013.05.010","article-title":"Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data","volume":"45","author":"Tsuboi","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.04.002_bb0295","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/JCP.0b013e3182214aad","article-title":"Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2019.04.002_bb0300","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e318218d339","article-title":"Predicting dopamine D(2) receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.schres.2019.04.002_bb0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.biopsych.2018.04.023","article-title":"Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium","volume":"84","author":"van Erp","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2019.04.002_bb0310","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archgenpsychiatry.2011.88","article-title":"Changes in cortical thickness during the course of illness in schizophrenia","volume":"68","author":"van Haren","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2019.04.002_bb0315","doi-asserted-by":"crossref","unstructured":"Vita, A., De Peri, L., Deste, G., Barlati, S., Sacchetti, E., 2015. The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies. Biol. Psychiatry.","DOI":"10.1016\/j.biopsych.2015.02.008"},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.04.002_bb0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.schres.2014.01.017","article-title":"Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data","volume":"153","author":"Yoshida","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419301252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419301252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:28:53Z","timestamp":1760297333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419301252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":64,"alternative-id":["S0920996419301252"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.04.002","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic treatment and basal ganglia volumes: Exploring the role of receptor occupancy, dosage and remission status","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}